Thrombocytopenia: the good, the bad and the ugly
- PMID: 35584828
- PMCID: PMC9135082
- DOI: 10.7861/clinmed.2022-0146
Thrombocytopenia: the good, the bad and the ugly
Abstract
New thrombocytopenia may be associated with a variety of conditions and diagnosis can be challenging. Presentation can vary from life-threatening bleeding or thrombosis to an incidental finding in an asymptomatic patient. New thrombocytopenia requires urgent investigation. Investigations are mainly guided by findings from the clinical history, physical examination, full blood count and blood film analysis. Aside from the actively bleeding patient, rare but life-threatening causes of thrombocytopenia must be identified early as they require urgent treatment. These include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, suspicion of new acute promyelocytic leukaemia, and vaccine-induced prothrombotic immune thrombocytopenia. Here, we discuss how to approach a patient with new thrombocytopenia, along with key differentials not to be missed.
Keywords: bleeding; haematology; platelets; thrombocytopenia; thrombosis.
© Royal College of Physicians 2022. All rights reserved.
Figures
References
-
- Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program 2012;2012:191–7. - PubMed
-
- Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood J Am Soc Hematol 2013;121:38–47. - PubMed
-
- Provan D, Stasi R, Newland A, et al. . International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–86. - PubMed
-
- Estcourt L, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions. 2016;176:365–94. - PubMed
-
- Scully M, Hunt BJ, Benjamin S, et al. . Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012;158:323–35. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
